Junfeng Wang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Efficacy and mechanisms of cisplatin and sulforaphane nanoparticles in alleviating cisplatin resistance in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: September 29, 2025
Peptide YY fragment PYY1-36 disrupts mitochondrial biogenesis via RBM43-dependent PGC-1α translation inhibition.
Journal: Investigational new drugs
Published: March 10, 2025
The relationship between blood biomarkers and prognosis of pathologic stage IA pure-solid non-small cell lung cancer patients.
Journal: Journal of thoracic disease
Published: December 02, 2024
Knockdown of LINC00511 decreased cisplatin resistance in non-small cell lung cancer by elevating miR-625 level to suppress the expression of leucine rich repeat containing eight volume-regulated anion channel subunit E.
Journal: Human & experimental toxicology
Published: April 01, 2022
CircKEAP1 Suppresses the Progression of Lung Adenocarcinoma via the miR-141-3p/KEAP1/NRF2 Axis.
Journal: Frontiers in oncology
Published: March 02, 2021
Constructing a global transcriptional regulatory landscape for early non-small cell lung cancer to identify hub genes and key pathways.
Journal: Aging
Published: February 11, 2020
circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma.
Journal: Cell death & disease
Published: August 05, 2019
Simvastatin Suppresses Proliferation and Migration in Non-small Cell Lung Cancer via Pyroptosis.
Journal: International journal of biological sciences
Published: October 29, 2017
miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.
Journal: Oncotarget
Published: January 23, 2017
CUTL1 induces epithelial-mesenchymal transition in non-small cell lung cancer.
Journal: Oncology reports
Published: October 22, 2016
Last Updated: 09/26/2026